ABET Outcome

Outcome (h):The broad education necessary to understand the

impact of engineering solutions in a global, economic,
environmental, and societal context.
Outcome (i): Recognition of the need for, and an ability to engage
in life-long learning.
Performance I ndicator i1: Acquires and evaluates information from multiple
sources to assess problems and interpret data

Course Objectives

Performance I ndicator j3: Awareness of how societal needs

drive engineering design.

Performance I ndicator j1: Demonstrates knowledge of current technological

issues and their relation to general society.
Performance I ndicator j2: Ability to describe the impact of governmental policy
and regulation on the practice of engineering.

Outcome (j): A knowledge of contemporary issues.

Know your curriculum

Know your professors
Know why you are taking these courses.
Know how each course is connected.
Know the skill sets expected of you.
Know your future career options.
Know the field of chemical/biomolecular
engineering profession.

Grading Policy

Unannounced quizzes: 30%

Final Exam: 70%
Class Participation: Extra credits

Ask questions in class

Answer questions in class.
Say your name before speaking.

Oct 3, Week 1: Introduction to Chemical and Biomolecular

Engineering
Oct 10, Week 2: Microelectronic Manufacturing option and
future outlook (Prof. Jane Chang)
Oct 17, Week 3: CBE curricula
Oct 24, Week 4: Prof. Dante Simonetti
Oct 31,Week 5: Energy outlook
Nov 7, Week 6: Petroleum and natural gas
Nov 14, Week 7: Biological manufacturing of chemicals and
fuels
Nov 21, Week 8: Industrial alumni talk: Anna Solis, Project
Management, Fluor
Dec 5 Week 9: Prof. Yvonne Chen
Dec 12, Week 10: Final Exam

Research Experience

Academic Integrity
EXTREMELY IMPORTANT

>-5%'$(-5*

?$%&'(#5*

>-5%'$(-5*

?$%&'(#5*

@/$*

!""%9/#)%"*

!"#$%&'(#)%"**#%**
+,-.)(/0*/"&*1)%.%0-('0/$*2"3)"--$)"3*

4/.-5*+6*7)/%*
8")9-$5)#:*%;*+/0);%$")/<*7%5*="3-0-5*

N/#'$/0*3/5*G-00*

BFMD*

2&G)"*76*H$/I-*

O)0*@-00*

J)#'59)00-<*?-""5:09/")/*

BFLD*

K)"-$/05*/5*2"-$3:*A%'$(-5**
/;#-$*)"&'5#$)/0*$-9%0'#)%"*
+%/0*

BFDD*

!"&'5#$)/0*>-9%0'#)%"*
7/#-*BF#,*(-"#'$:*

BEDD*

1)%./55*

BFDD*

@,/0)"3*

1)%0%3:*/5*2"-$3:*A%'$(-5*
1-;%$-*!"&'5#$)/0*>-9%0'#)%"*
=")./0**

BCDD*

1-##-$*7);-*

!"&'5#$)/0*$-9%0'#)%"*

1/(#-$)/*;)S*")#$%3-"*;%$*P0/"#5T*
NM*NUV**/.)"%*/()&5<*"'(0-%#)&-5*
*
A/0#P-#-$*WN/NOVX**NOVY***NOMY*NUV*

?0/"#5*&%*"%#*;)S*")#$%3-"6*

Q%%&*5%'$(-5*0).)#-&*R:*$-&'(-&*")#$%3-"*
/5*P%P'0/#)%"*)"($-/5-&*

*
Population (in billions)

?%P'0/#)%"*3$%G#,*

Q%%&*&-./"&*

+)$(/*BFFDT**J,-*Q-$#)0)Z-$*@/$*
J,-*!"#$%&$'()$*"+,&,+**
d^t*
BFE[YBFFV*

J,-*N)#$%3-"*+:(0-*

*
=#*#,-*R-3)"")"3*%;*#,-*MD#,*#,-*
(-"#'$:<*/00*(%'"#$)-5*).P%$#-&*
5/0#P-#-$*WN/NOVX*;$%.*+,)0-**
K/":*5()-"#)5#5*G-$-*G%$$)-&*
/R%'#*#,-*&-(0)")"3*5'PP0:*%;*
")#$%3-"*(%.P%'"&56*
=*G/$*R$%I-*%'#*R-#G--"*+,)0-<*
1%0)9)/*/"&*?-$'<*(/'5-&*R:*
5/0#P-#-$*.)")"3*)55'-56*

Nitrogen fixation

Denitrification

BL*

J,-*U/R-$Y1%5(,*?$%(-55*$-0)-9-5*#,-*
$-0)/"(-*%"*-S)5#)"3*")#$/#-*5/0#5**

+,-.)5#$:*)"9-"#-&*R:*Q$)#Z*U/R-$*WN%R-0*P$)Z-*B[BFX**
?$%(-55*)"9-"#-&*R:*+/$0*1%5(,*WN%R-0*P$)Z-*B[VBX*
?$-55'$-T**
*******BLD**/#.**
J-.PT**
*******VED*Y*LDD*%+*
+/#/0:5#T*
*******!$%"*%S)&-*
CO2

U/R-$Y1%5(,*?$%(-55*
B[D[*

NM*\*VUM**MNUV*

1"#2$3%4+(**
N%R-0*?$)Z-*)"*+,-.)5#$:*WB[VBX*

BLML*K?/*WM<MDDV<CDD*P5)X**
VDDLLD*]+**

-#,'.$/"0)#*
N%R-0*?$)Z-*)"*+,-.)5#$:*WB[BFX*

+)$(/*B[BMT**+,/).*@-)Z./""**

+%$&)#-*
*
?$%P-00/"#*;%$*R'00-#5*

B[BMT*O$3/")5.*)&-"#);)-&*
B[BLT*?)0%#*?0/"#*R')0#*
B[BCT*?$%&'(#)%"*%;*VD<DDD*#%"5*%;*=(-#%"-***
*

=(-#%"-<*1'#/"%0<*2#,/"%0*Q-$.-"#/#)%"*
!"#$%&'(')*+,-.%#/)%0"'-)*****

+,/).*@-)Z./""*

Population (in billions)

?%5)#)9-*!.P/(#*%;**
#,-*U/R-$Y1%5(,*?$%(-55*

Clostridium acetobutylicum

10

6
4
2
0

!%#25$6%672"',%8$(,'4$9$0,22,%8$$
%8$:+';$<=>$?@==$$ABC$D,E)4F

500 million tons of artificial fertilizer per year.

1-2% of the world's energy supply is used for it (Science, 2002)
Synthetic fertilizer is responsible for sustaining one-third of the
earth's population

J%$%"#%<*+/"/&/*

?-#$%0-'.*$-;)")"3*)"*B[MDYB[VD*

A#/"&/$&*O)0<**20*A-3'"&%<*+/0);%$")/*

@@!*
B[B^YB[BF*

J,-*?-#$%0-'.*@/$*Y*@@!!*

MV*

=.-$)(/"*%)0*2.R/$3%*/3/)"5#*4/P/"*W4'0:*B[^BX*
?-/0*U/$R%$*=##/(I*WH-(-.R-$*B[^BX*

/"84$D#%64+(*

!"#$%&'"(")!%&'"%*#)!*'+%,'"("#$!%&'"(")!$*

A:"#,-#)(*3/5*

Q)5(,-$YJ$%P5(,*?$%(-55*
B[MV_*

`)#%*A#/30)/"%**
U/$$)5*A(,%%0*%;*?'R0)(*?%0)(:*A#'&)-5*/#*#,-*8")9-$5)#:*%;*+,)(/3%**
O(#%R-$*M[<*MDDE**

*
*

-#"8.$-,4+()#*

c)'0)%*N/##/*

+/*B[LDT*a)-30-$YN/##/*+/#/0:5#*

"*+UM,Z,M,Z"*

W*

b/$0*a)-30-$*

N%R-0*?$)Z-*;%$*+,-.)5#$:*B[CV*

4/P/"*&'$)"3*@@*!!*

N/9:*G/"#-&*#%*)"($-/5-*1'#/"-Y1'#:0-"-*
;$/(#)%"*/9)/#)%"*;'-0*
Q-$.-"#/#)%"*#%*P$%&'(-*"Y1'#/"%0*

/#*J/)G/"*A)S#,*N/9/0*Q'-0*H-P%#*

H-,:&$/#)%"*#%*/"&*)5%.-$)Z/#)%"*#%*P$%&'(-*
*****)5%R'#:0-"-*
*
*

Louis
Pasteur

1861

1900

Gustav Embden
Otto Meyerhof

Glycolysis (EMP)

1932

Hans Krebs

TCA cycle
Urea cycle

1950-1960

Melvin Calvin,
Andrew Benson
James Bassham

Calvin cycle
(CBB cycle)

1)%(,-.)(/0*P/#,G/:5*

B[LDYP$-5-"#*

27

MC*

1)%#-(,"%0%3:*B[FDYP$-5-"#*
=")./0*(-00*('0#'$-*
1)%YP,/$./(-'#)(/05*
="#)R%&:*#,-$/P:*
+-00YR/5-&*#,-$/P:*
H$'3*&-0)9-$:*
J)55'-*2"3)"--$)"3*
K-#/R%0)(*2"3)"--$)"3*
*

1)%#-(,"%0%3:*B[LDYB[FD*

?-")()00)"*Q-$.-"#/#)%"*
+)#$)(*/()&*;-$.-"#/#)%"*
`)#/.)"*1BM*;-$.-"#/#)%"*
c0'#/.)(*/()&*;-$.-"#/#)%"*
7:5)"-*Q-$-.-"#/#)%"*

+'$$-"#e;'#'$-*+,/00-"3-5*

1)%#-(,"%0%3:*)"*#,-*MB5#*(-"#'$:T*
c-"%.-*A-d'-"()"3*/"&*c-"-*A:"#,-5)5*

MDBD**;'#'$-T*?%P'0/#)%"*3$%G#,*G)00*
&$)9-*#,-*-"-$3:*&-./"&*

A%'$(-T**2SS%"*K%R)0<*J,-*%'#0%%I*;%$*-"-$3:T*/*9)-G*#%*MD^D*

+,-.)(/0*/"&*1)%.%0-('0/$*2"3)"--$)"3*

2"-$3:<**
+,-.)(/05*

@,-$-*&%*G-*3%*;$%.*,-$-h*

K-&)()"-*
20-(#$%")(*
./#-$)/05*

^DD
VLD

VDD
MLD
MDD

BLD

^DD
VEL
VLD
VML
VDD
MEL
MLD
D

VFD

MDD

^DD

CDD

FDD

f-/$ W=6HX

BDDD BMDD B^DD BCDD BFDD MDDD

MFD
BFD
FD
D(%74"854$%&$G)"#4$0)&%#)$6#)4)8'$5"H

YMD

V^*

MDBD*Y*Q'#'$-T***+OM*/(('.'0/#)%"*R-(%.-5*/*
./g%$*(%"(-$"*

1:? +%8+)8'#"',%8$A66EF